These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26054944)

  • 1. Estimation of life expectancy and the expected years of life lost among heroin users in the era of opioid substitution treatment (OST) in Taiwan.
    Chang KC; Lu TH; Lee KY; Hwang JS; Cheng CM; Wang JD
    Drug Alcohol Depend; 2015 Aug; 153():152-8. PubMed ID: 26054944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan.
    Chang KC; Wang JD; Saxon A; Matthews AG; Woody G; Hser YI
    Int J Drug Policy; 2017 May; 43():1-6. PubMed ID: 28160734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicide and other-cause mortality among heroin users in Taiwan: a prospective study.
    Lee CT; Chen VC; Tan HK; Chou SY; Wu KH; Chan CH; Gossop M
    Addict Behav; 2013 Oct; 38(10):2619-23. PubMed ID: 23851391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid agonist treatment reduces losses in quality of life and quality-adjusted life expectancy in heroin users: Evidence from real world data.
    Chang KC; Lee KY; Lu TH; Hwang JS; Lin CN; Ting SY; Chang CC; Wang JD
    Drug Alcohol Depend; 2019 Aug; 201():197-204. PubMed ID: 31247504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death from liver disease in a cohort of injecting opioid users in a Swedish city in relation to registration for opioid substitution therapy.
    Jerkeman A; Håkansson A; Rylance R; Wagner P; Alanko Blomé M; Björkman P
    Drug Alcohol Rev; 2017 May; 36(3):424-431. PubMed ID: 27241955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Years of potential life lost amongst heroin users in the Australian Treatment Outcome Study cohort, 2001-2015.
    Darke S; Marel C; Mills KL; Ross J; Slade T; Tessson M
    Drug Alcohol Depend; 2016 May; 162():206-10. PubMed ID: 27021806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan.
    Lêng CH; Chou MH; Lin SH; Yang YK; Wang JD
    Schizophr Res; 2016 Mar; 171(1-3):97-102. PubMed ID: 26811230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that affect life expectancy of patients with gastric adenocarcinoma.
    Chen WY; Cheng HC; Wang JD; Sheu BS
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1595-600. PubMed ID: 23811250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life expectancy and expected years of life lost to oral cancer in Taiwan: a nation-wide analysis of 22,024 cases followed for 10 years.
    Huang CC; Ou CY; Lee WT; Hsiao JR; Tsai ST; Wang JD
    Oral Oncol; 2015 Apr; 51(4):349-54. PubMed ID: 25604257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates.
    Chu PC; Wang JD; Hwang JS; Chang YY
    Value Health; 2008 Dec; 11(7):1102-9. PubMed ID: 18489497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with mortality among heroin users after seeking treatment with methadone: a population-based cohort study in Taiwan.
    Huang CL; Lee CW
    J Subst Abuse Treat; 2013 Mar; 44(3):295-300. PubMed ID: 23021097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive suicide mortality and risk factors for suicide among patients with heroin dependence.
    Pan CH; Jhong JR; Tsai SY; Lin SK; Chen CC; Kuo CJ
    Drug Alcohol Depend; 2014 Dec; 145():224-30. PubMed ID: 25456334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess mortality and shortened life expectancy in people with major mental illnesses in Taiwan.
    Pan YJ; Yeh LL; Chan HY; Chang CK
    Epidemiol Psychiatr Sci; 2020 Aug; 29():e156. PubMed ID: 32792024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence.
    Gisev N; Shanahan M; Weatherburn DJ; Mattick RP; Larney S; Burns L; Degenhardt L
    Addiction; 2015 Dec; 110(12):1975-84. PubMed ID: 26212260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan.
    Chen PC; Lee JC; Wang JD
    PLoS One; 2015; 10(7):e0133755. PubMed ID: 26207912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating Life Expectancy and Lifetime Healthcare Costs for Alzheimer's Disease in Taiwan: Does the Age of Disease Onset Matter?
    Yeh TS; Wang JD; Ku LE
    J Alzheimers Dis; 2020; 73(1):307-315. PubMed ID: 31771049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of substance use and mortality risk in a cohort of 'hard-to-reach' polysubstance users.
    Gjersing L; Bretteville-Jensen AL
    Addiction; 2018 Apr; 113(4):729-739. PubMed ID: 28987019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of death in a cohort treated for opioid dependence between 1985 and 2005.
    Degenhardt L; Larney S; Randall D; Burns L; Hall W
    Addiction; 2014 Jan; 109(1):90-9. PubMed ID: 23961881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-standardized expected years of life lost: quantification of cancer severity.
    Wang Y; Chiang CJ; Lee WC
    BMC Public Health; 2019 May; 19(1):486. PubMed ID: 31046731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of expected health impacts for major cancers: integration of incidence rate and loss of quality-adjusted life expectancy.
    Hung MC; Lai WW; Chen HH; Su WC; Wang JD
    Cancer Epidemiol; 2015 Feb; 39(1):126-32. PubMed ID: 25553846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.